SCHEMBL1216909

SCHEMBL1216909

CN(Cc1ccccc1F)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2F)c(O)cc1O

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.53
MAOA P21397 2/20 0.40
CASP3 P42574 2/20 0.40
MAOB P27338 1/20 0.40
NR3C2 P08235 1/20 0.38
PDE10A Q9Y233 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.34
PDE11A Q9HCR9 1/20 0.34
POLB P06746 1/20 0.34
MAPK14 Q16539 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM5A P29375 1/20 0.33
KDM5B Q9UGL1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1218724 0.94 HSP90AA1 (0.49) HSP90AA1MAOACASP3MAOBNR3C2
SCHEMBL1219566 0.93 HSP90AA1 (0.50) HSP90AA1MAOACASP3MAOBNR3C2
SCHEMBL1217812 0.93 HSP90AA1 (0.50) HSP90AA1MAOACASP3MAOBNR3C2
SCHEMBL1218940 0.92 HSP90AA1 (0.49) HSP90AA1MAOACASP3MAOBNR3C2
SCHEMBL1219682 0.90 HSP90AA1 (0.53) HSP90AA1NR3C2PDE10ASMN1; SMN2POLB
SCHEMBL1218767 0.89 HSP90AA1 (0.48) HSP90AA1NR3C2PDE10ASMN1; SMN2HSD17B10
SCHEMBL1218863 0.89 HSP90AA1 (0.46) HSP90AA1NR3C2PDE10ASMN1; SMN2MEN1
SCHEMBL1219638 0.89 HSP90AA1 (0.52) HSP90AA1MAOACASP3MAOBNR3C2
SCHEMBL1219470 0.89 HSP90AA1 (0.52) HSP90AA1NR3C2PDE10ASMN1; SMN2HSD17B10
SCHEMBL1219255 0.88 HSP90AA1 (0.46) HSP90AA1MAOACASP3MAOBNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS EGGENWEILER HANS-MICHAEL 2011-02-03 US claimed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US claimed
US-7906657-B2 1,5-diphenylpyrazoles II as HSP90 inhibitors MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2011-03-15 US disclosed
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS EGGENWEILER HANS-MICHAEL 2011-02-03 US disclosed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885MAOA 4236/4885CASP3 2334/4885
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885MAOA 4236/4885CASP3 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.